
Indegene Technical Momentum Shifts Amid Mixed Market Signals
2025-12-02 08:13:35Indegene, a key player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a subtle change in the stock’s price dynamics, with technical indicators such as MACD, RSI, and moving averages offering a mixed perspective on its near-term trajectory.
Read More
Indegene Technical Momentum Shifts Amid Mixed Market Signals
2025-11-26 08:11:20Indegene, a key player in the Healthcare Services sector, is currently exhibiting a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent evaluation adjustments highlight a transition in market assessment, with technical indicators such as MACD, RSI, and moving averages providing a mixed outlook for investors navigating this small-cap stock.
Read More
Indegene’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts
2025-11-25 09:03:10Indegene, a key player in the Healthcare Services sector, has undergone a revision in its market evaluation following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite flat quarterly financial results and subdued stock returns over the past year, shifts in technical patterns and institutional interest have influenced the overall market perspective on the company.
Read More
Indegene Shows Mixed Technical Signals Amidst Market Volatility
2025-11-25 08:15:46Indegene, a key player in the Healthcare Services sector, is exhibiting a complex blend of technical indicators that reflect a nuanced price momentum shift. Recent market data reveals a transition in technical trends, with some signals pointing towards cautious optimism while others suggest ongoing challenges in the stock’s trajectory.
Read MoreHow has been the historical performance of Indegene?
2025-11-24 23:31:13Revenue and Profit Growth Trajectory Indegene’s net sales have shown a robust upward trajectory, increasing from ₹1,664.61 crores in March 2022 to ₹2,839.30 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 27.5%, reflecting strong demand and effective business expansion strategies. Total operating income mirrors this trend, as other operating income remained nil throughout the period. Operating profit before depreciation and interest (PBDIT excluding other income) rose steadily from ₹286.92 crores in 2022 to ₹534.30 crores in 2025, indicating improved operational efficiency. When factoring in other income, operating profit (PBDIT) increased from ₹312.81 crores to ₹641.50 crores over the same period. This growth was accompanied...
Read MoreWhy is Indegene falling/rising?
2025-11-11 00:24:02As of 10-Nov, Indegene Ltd's stock price is currently at 518.15, reflecting a decrease of 5.0, or 0.96%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.76% during this period. Additionally, the stock has shown a significant negative performance over various time frames, with a year-to-date decline of 14.21% and a one-year drop of 24.77%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a Price to Book Value of 0.4, the company's recent quarterly results showed a decline in profit after tax, which may have contributed to the stock's downward movement. Furthermore, while institutional investors have increased their stake by 7.05%, the overall sentiment remains cautious due to the stock's underperformance compared to broader market indices. In the broader market context, Indegene's short-term performance has...
Read More
Indegene Experiences Technical Trend Shift Amidst Bearish Market Sentiment
2025-11-07 08:10:41Indegene, a small-cap healthcare services company, is experiencing a bearish trend in its stock performance, currently priced at 530.10. The stock has underperformed against the Sensex over various time frames, with notable declines in weekly, monthly, and yearly returns, reflecting ongoing market challenges.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
31-Jan-2026 | Source : BSEIntimation of Newspaper Publication.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
30-Jan-2026 | Source : BSEAudio Recording of the Q3FY26 Earnings Call.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
29-Jan-2026 | Source : BSEPress Release
Corporate Actions
No Upcoming Board Meetings
Indegene Ltd has declared 100% dividend, ex-date: 13 Jun 25
No Splits history available
No Bonus history available
No Rights history available